References
Cornelius JF, Slotty PJ, Kamp MA, Schneiderhan TM, Steiger HJ, El-Khatib M (2014) Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas—with special regard to high-grade tumors. Photodiagn Photodyn Ther 11:481–490
Cornelius JF, Slotty PJ, Stoffels G, Galldiks N, Langen KJ, Steiger HJ (2013) 5-Aminolevulinic acid and 18F-FET-PET as metabolic imaging tools for surgery of a recurrent skull base meningioma. J Neurol Surg B Skull Base 74:211–216
Evers G, Kamp M, Warneke N, Berdel WE, Sabel M, Stummer W, Ewelt C (2016) 5-aminolaevulinic acid-induced fluorescence in primary central nervous system lymphoma. World Neurosurg
Kamp MA, Fischer I, Buhner J, Turowski B, Cornelius JF, Steiger HJ, Rapp M, Slotty PJ, Sabel M (2016) 5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression. Oncotarget
Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger G, Sabel M (2012) 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir 154:223–228 discussion 228
Kamp MA, Santacroce A, Zella S, Reichelt DC, Felsberg J, Steiger HJ, Cornelius JF, Sabel M (2012) Is it a glioblastoma? In dubio pro 5-ALA! Acta Neurochir 154:1269–1273
Marbacher S, Klinger E, Schwyzer L, Fischer I, Nevzati E, Diepers M, Roelcke U, Fathi AR, Coluccia D, Fandino J (2014) Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus 36:E10
Millesi M, Kiesel B, Mischkulnig M, Martinez-Moreno M, Wohrer A, Wolfsberger S, Knosp E, Widhalm G (2016) Analysis of the surgical benefits of 5-ALA-induced fluorescence in intracranial meningiomas: experience in 204 meningiomas. J Neurosurg 125:1408–1419
Nestler U, Warter A, Cabre P, Manzo N (2012) A case of late-onset multiple sclerosis mimicking glioblastoma and displaying intraoperative 5-aminolevulinic acid fluorescence. Acta Neurochir 154:899–901
Stummer W, Kamp MA (2009) The importance of surgical resection in malignant glioma. Curr Opin Neurol 22:645–649
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, Group AL-GS (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401
Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, Plesnila N, Wietzorrek J, Reulen HJ (1998) In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 45:160–169
Voellger B, Klein J, Mawrin C, Firsching R (2014) 5-aminolevulinic acid (5-ALA) fluorescence in infectious disease of the brain. Acta Neurochir 156:1977–1978
Yamamoto T, Ishikawa E, Miki S, Sakamoto N, Zaboronok A, Matsuda M, Akutsu H, Nakai K, Tsuruta W, Matsumura A (2015) Photodynamic diagnosis using 5-Aminolevulinic acid in 41 biopsies for primary central nervous system lymphoma. Photochem Photobiol 91:1452–1457
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Funding
The present study was not funded.
Conflict of interest
Prof. Sabel is a consultant for Johnson & Johnson Company and Integra Company. All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
The local Research Ethics Committee and institutional review board stated that an ethic committee vote is not required for the present manuscript.
Informed consent
Informed consent was obtained.
Rights and permissions
About this article
Cite this article
Steinmann, J., Rapp, M., Turowski, B. et al. 5-ALA fluorescence behavior of cerebral infectious and inflammatory disease. Neurosurg Rev 41, 365–369 (2018). https://doi.org/10.1007/s10143-017-0867-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-017-0867-3